Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.

Høibraaten E, Mowinckel MC, de Ronde H, Bertina RM, Sandset PM.

Br J Haematol. 2001 Nov;115(2):415-20.

PMID:
11703344
2.

Effects of oral contraceptives on hemostasis and thrombosis.

Rosing J, Tans G.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S375-82. Review.

PMID:
10368524
4.

Hormone therapy and venous thromboembolism.

Peverill RE.

Best Pract Res Clin Endocrinol Metab. 2003 Mar;17(1):149-64. Review.

PMID:
12763518
5.

Molecular biology and pathophysiology of APC resistance: current insights and clinical implications.

Rosing J, Hemker HC, Tans G.

Semin Thromb Hemost. 1998;24(4):329-35. Review.

PMID:
9763350
6.

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.

Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF.

Arch Intern Med. 1997 Jul 28;157(14):1522-30. Review.

PMID:
9236553
7.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

8.
9.

Factor V Leiden and venous thromboembolism: risk associated with hormone replacement therapy.

Park BD, Lookinland S, Beckstrand RL, Chasson S.

J Am Acad Nurse Pract. 2003 Oct;15(10):458-66. Review.

PMID:
14606135
10.

Oral contraceptives, thrombosis and haemostasis.

Rosing J, Curvers J, Tans G.

Eur J Obstet Gynecol Reprod Biol. 2001 Apr;95(2):193-7. Review.

PMID:
11301170
11.

[Effects of second and third generation oral contraceptives on hemostasis].

Middeldorp S, Rosing J, Bouma BN, Büller HR.

Ned Tijdschr Geneeskd. 2001 Feb 10;145(6):252-6. Review. Dutch.

PMID:
11236370
12.
13.

[Analysis of phenotype resistance to activated protein C (APC resistance)].

Hudecek J, Ivanková J, Dobrotová M, Hybenová J, Pullmann R, Kubisz P.

Vnitr Lek. 1999 Dec;45(12):723-8. Review. Czech.

PMID:
10951849
14.

HRT and the risk of deep vein thrombosis.

Barlow DH.

Int J Gynaecol Obstet. 1997 Oct;59 Suppl 1:S29-33. Review.

PMID:
9386213
15.

[From pill to pill: oral contraception, venous thrombosis and coagulation disorders].

Vandenbroucke JP.

Verh K Acad Geneeskd Belg. 2001;63(3):243-52; discussion 252-5. Review. Dutch.

PMID:
11499345
16.

Venous thrombosis after extracorporeal shock-wave lithotripsy in a patient with heterozygous APC-resistance.

Brodmann M, Ramschak H, Schreiber F, Stark G, Pabst E, Pilger E.

Thromb Haemost. 1998 Nov;80(5):861. Review. No abstract available.

PMID:
9843186
17.

Hormone therapies and vascular outcomes: who is at risk?

Cushman M.

J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):87-90. Review.

PMID:
14760220
18.

Oral contraceptives and thrombosis.

Thorogood M.

Curr Opin Hematol. 1998 Sep;5(5):350-4. Review.

PMID:
9776215
19.

Hormonal influences on hemostasis in women.

Trigg DE, Wood MG, Kouides PA, Kadir RA.

Semin Thromb Hemost. 2011 Feb;37(1):77-86. doi: 10.1055/s-0030-1270074. Epub 2011 Jan 19. Review.

PMID:
21249605
20.

Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.

Castellsague J, Pérez Gutthann S, García Rodríguez LA.

Drug Saf. 1998 Feb;18(2):117-23. Review.

PMID:
9512918
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk